Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2-lambda |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Tezepelumab Biosimilar - Anti-TSLP mAb - Research Grade |
|---|---|
| Source | CAS 1572943-04-4 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Tezepelumab,AMG 157,AMG-157,MEDI-9929,MEDI9929,anti-TSLP-Receptor (TSLP-R; Crl2),TSLP,anti-TSLP |
| Reference | PX-TA1399 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-lambda |
| Clonality | Monoclonal Antibody |
Tezepelumab is investigated in the treatment of Oral Corticosteroid Dependent Asthma.
Tezepelumab Biosimilar - Anti-TSLP mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.